<div>Comprehensive Whole Genome Sequencing and Whole Transcriptome (RNASeq) analyses from 114 pediatric patients at Memorial Sloan Kettering. This dataset was used as a prospective clinical utility and feasibility study. By using our <a href="https://bmcbioinformatics.biomedcentral.com/articles/10.1186/s12859-020-03879-7">Isabl</a> infrastructure for precision medicine, we developed a 2-week end-to-end pipeline to analyze cfDNA, WGS and WTS, which we refer to as cWGTS.</div>

Feasibility and Clinical Utility of Whole Genome Profiling in Pediatric    and Young Adult Cancers

14 variables across Demographics, Disease Events

Feasibility and Clinical Utility of Whole Genome Profiling in Pediatric and Young Adult Cancers

Demographics (2)

Disease Events (4)

Other (8)